SEC 13F Intelligence

Propel Bio Management, LLC / MDGL

Propel Bio Management, LLC’s Madrigal Pharmaceuticals Inc Position

Does Propel Bio Management, LLC own Madrigal Pharmaceuticals Inc (MDGL)? Not currently — the last reported position was 30.0K shares worth $10M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q1 2025
Shares
30.0K
% of Portfolio
+11.56%
Quarters Held
6
position exited

Position History MDGL

Reported value by quarter
Q4 ’23: $7MQ4 ’23Q1 ’24: $11MQ1 ’24Q2 ’24: $12MQ2 ’24Q3 ’24: $9MQ3 ’24Q4 ’24: $13MQ4 ’24Q1 ’25: $10MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202530.0K$10M+11.56%
Q4 202443.0K$13M+13.19%
Q3 202443.0K$9M+5.30%
Q2 202443.0K$12M+7.82%
Q1 202443.0K$11M+6.69%
Q4 202330.0K$7M+5.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of MDGL.